Dr. King is Chief Science and Business Officer as well as co-founder of BioAccel. Dr. King brings more than 23 years of experience in health technology, business, and policy management in both public and private sectors. Prior to starting BioAccel, Dr. King was the Vice President of Business and Strategic Partnerships at The Translational Genomics Research Institute (TGen) where he was responsible for alliance management, business development, and technology commercialization. Dr. King has held several senior level positions at the National Institutes of Health, including: Associate Director of Intramural Research and Director of Technology Transfer at the National Human Genome Research Institute. He holds an MBA from Arizona State University, and certifications and training from the Haas School of Business at the University of California, Berkeley.